𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors

✍ Scribed by Yuka Sasakawa; Yoshinori Naoe; Takahisa Noto; Takeshi Inoue; Tatsuya Sasakawa; Masahiko Matsuo; Toshitaka Manda; Seitaro Mutoh


Book ID
113993631
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
468 KB
Volume
66
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of novel histone deacetylase inhi
✍ Kojiro Taura; Yuzo Yamamoto; Akio Nakajima; Koichiro Hata; Hiroshi Uchinami; Kei πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 475 KB

## Abstract ## Background Histone deacetylase inhibitors (HDIs) are known to enhance adenovirus (Ad)‐mediated transgene expression. Recently, novel HDIs, including cyclic hydroxamic‐acid‐containing peptide 31 (CHAP31) and FR901228 (FK228), have been developed. ## Methods The effects of these two